I schemic postconditioning (IPoC) reduces infarct size by attenuation of reperfusion injury 1 and is operative in all species studied so far, including humans. 2,3 The phosphorylation of RISK (reperfusion injury salvage kinases), ie, phosphatidylinositol 3-kinase/protein kinase B (PI3K-AKT), 4,5 mitogen-activated protein kinase kinase/extracellular signal regulated kinase (ERK) (MEK1/2-ERK1/2), 6 p70 ribosomal S6 protein kinase (P70S6K), and glycogen synthase kinase (GSK)3␤ was proposed to be causal for protection by IPoC. 4 -7 Activation of sarcolemmal receptors projects through parallel pathways of either PI3K-AKT or MEK1/2-ERK1/2 onto P70S6K and ultimately on GSK3␤, which, when phosphorylated, inhibits mitochondrial permeability transition pore opening. 8 Whether specific RISK kinases or a concert of different RISK kinases confer the protection by postconditioning is less clear. 4, 6, 7, 9, 10 In 2 studies, there was RISK phosphorylation but no protection by postconditioning. 11, 12 Most studies on the role of RISK in postconditioning were performed in rodent hearts, 4,6,7 which, apart from species differences to larger mammals including humans, may pose methodological limitations: the small amount of tissue available for Western blots permits neither determination of baseline values nor that of infarct size in an individual heart. The association of RISK phosphorylation with less infarction could therefore be cause or consequence of the observed protection.
I schemic postconditioning (IPoC) reduces infarct size by attenuation of reperfusion injury 1 and is operative in all species studied so far, including humans. 2, 3 The phosphorylation of RISK (reperfusion injury salvage kinases), ie, phosphatidylinositol 3-kinase/protein kinase B (PI3K-AKT), 4,5 mitogen-activated protein kinase kinase/extracellular signal regulated kinase (ERK) (MEK1/2-ERK1/2), 6 p70 ribosomal S6 protein kinase (P70S6K), and glycogen synthase kinase (GSK)3␤ was proposed to be causal for protection by IPoC. 4 -7 Activation of sarcolemmal receptors projects through parallel pathways of either PI3K-AKT or MEK1/2-ERK1/2 onto P70S6K and ultimately on GSK3␤, which, when phosphorylated, inhibits mitochondrial permeability transition pore opening. 8 Whether specific RISK kinases or a concert of different RISK kinases confer the protection by postconditioning is less clear. 4, 6, 7, 9, 10 In 2 studies, there was RISK phosphorylation but no protection by postconditioning. 11, 12 Most studies on the role of RISK in postconditioning were performed in rodent hearts, 4, 6, 7 which, apart from species differences to larger mammals including humans, may pose methodological limitations: the small amount of tissue available for Western blots permits neither determination of baseline values nor that of infarct size in an individual heart. The association of RISK phosphorylation with less infarction could therefore be cause or consequence of the observed protection.
The present study evaluates the role of RISK for postconditioning in pigs. With regard to size, coronary anatomy, and heart rate, the pig heart resembles more closely the human heart than smaller species, and it permits taking multiple biopsies at different time points and determining infarct size in an individual heart.
Materials and Methods
The experiments were performed in an established pig model of regional ischemia/reperfusion with infarct size determination and Western blot analysis (see the expanded Materials and Methods section in the online data supplement, available at http://circres. ahajournals.org).
Protocol 1
IPoC (nϭ13) was induced by 6 cycles of 20 seconds of reperfusion and 20 seconds of reocclusion at the onset of reperfusion. Immediate full reperfusion (IFR) (nϭ15) was established for comparison.
Protocol 2
In 8 animals, 4 with IPoC (B-IPoC) and 4 with IFR (B-IFR), the 2 major upstream RISK pathways PI3K-AKT and MEK1/2-ERK1/2 were blocked before the onset of reperfusion (see the online data supplement).
Statistics
Data are meansϮSEM. Data were analyzed by 2-way ANOVA for repeated measures with least significant difference tests or doublesided t tests; PϽ0.05 was considered significant.
Results
Systemic hemodynamics (Table I in the online data supplement), area at risk (AAR), and subendocardial blood flow at 5 minutes of ischemia (supplemental Table II) Baseline total and phosphorylated kinases were not different between IPoC and IFR (supplemental Table III) ; total kinase content did not change throughout the experiment. RISK phosphorylation at 10 minutes of reperfusion was not different in samples from infarcted versus viable tissue (see the online data supplement). In the remote control region, RISK phosphorylation remained unchanged throughout the protocols and was not different between IPoC and IFR. In the AAR, the phosphorylation of AKT, ERK1/2, and p70S6K tended to decrease at the end of ischemia, whereas the phosphorylation of GSK3␤ tended to increase (Figure) . The phosphorylation of AKT, ERK1/2, p70S6K, and GSK3␤ then increased up to 30 minutes of reperfusion and tended to decrease thereafter, without significant differences between IPoC and IFR. RISK blockade before reperfusion abolished the increases in phosphorylation of AKT, ERK1/2, p70S6K, and GSK3␤ at 10 and 30 minutes of reperfusion (supplemental Figure I ).
Discussion
Ischemic postconditioning reduces infarct size after ischemia/ reperfusion in pigs, which was previously contentious. 11, 13 The notion that myocardial salvage by ischemic postconditioning causally involves RISK phosphorylation 14 is not supported by our study: RISK phosphorylation was indeed increased during reperfusion, however, not different between IPoC versus IFR. Also, postconditioning was still effective after RISK blockade by intracoronary coinfusion of Wortmannin and U0126. RISK blockade during the initial 30 minutes reperfusion was considered sufficient, because postconditioning must be initiated rapidly with the onset of reperfusion, RISK phosphorylation was maximal after 30 minutes of reperfusion and not different between IPoC and IFR afterward, and infarct size by TTC staining does not change when reperfusion is extended beyond 30 minutes up to 120 or even 270 minutes. 15 So, why is RISK activation not important for postconditioning in pigs? An obvious, but unsatisfying, explanation relates to species differences between rodents and larger mammals. However, the role of individual RISK kinases in postconditioning was not unequivocal before: simultaneous phosphorylation of AKT and ERK1/2, 16 but also of only ERK1/2 and not AKT, 12 has been reported in mice. Blockade of AKT phosphorylation abrogated postconditioning in rats 4 and rabbits 7 but not mice. 12 The role of GSK3␤ in pre-and postconditioning was recently questioned. 17 Because genetically modified mice were used and data were in contrast to a prior study in the same strain, 18 a caveat for the potential compensation by other mechanisms was voiced that might have precluded firm conclusions on the role of GSK3␤. 19 In this respect, our approach with acute pharmacological RISK blockade is superior, although it possibly lacks specificity and has to be seen in context with the lack of difference in RISK phosphorylation between IPoC and IFR. Our study goes beyond the above studies in that it questions the role of not only a specific RISK kinase but the entire RISK program in postconditioning. The hierarchical organization of RISK kinases, however, was confirmed because blockade of PI3K-AKT and MEK1/2-ERK1/2 also reduced P70S6K and GSK3␤ phosphorylation.
Having excluded RISK, what mediates postconditioning in pigs? Maintenance of acidosis, possibly with subsequent inhibition of mitochondrial permeability transition pore opening, is another hypothesis of how postconditioning might protect from infarction. 20 However, persistent acidosis at early reperfusion is again linked to RISK phosphorylation, 9 leaving open whether acidosis per se or RISK phosphorylation is responsible for the observed protection.
The STAT3 (signal transducer and activator of transcription 3) is important for ischemic postconditioning in mice 21 and also involved in protection by insulin at early reperfusion in isolated rat hearts. 22 Sphingosine kinase-1, the key enzyme that catalyzes the formation of sphingosine-1-phosphate, is also important for postconditioning in mice, 23 and sphingosine kinase activation is probably mediated by STAT3. 24 Whereas the present study revealed major differences in signal transduction by RISK between rodents and pigs, both sphingosine 25 and STAT3 26 are parts of the signal transduction of tumor necrosis factor (TNF)␣-induced cardioprotection, TNF␣-induced cardioprotection does not rely on AKT and ERK1/2, 26 and TNF␣ is also cardioprotective in pigs. 27 Thus, the role of STAT3 and sphingosine kinase in ischemic postconditioning in pigs or other large mammals should be studied further.
A caveat related to almost all studies on the signal transduction of IPoC, to date, is the fact that the specific cellular (cardiomyocyte, endothelium, fibroblast, leukocyte) and subcellular (cytosol, mitochondria, nucleus, signalosome) compartment of the respective kinase activation is not known. 
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